Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Bioregulators
Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium.
Peptide B
Bioregulators
Khavinson short peptide bioregulator targeting hepatocytes and liver function.
Typical vial
20 mg
Typical dose
1,000-5,000 mcg
Half-life
Short (minutes); biological effect persists via gene-expression modulation
FDA status
Not FDA approved.
Typical vial
20 mg
Typical dose
1,000-5,000 mcg
Half-life
Short (minutes); biological effect persists via gene-expression modulation
FDA status
Not FDA approved.
Cardiogen effects
Ovagen effects
Cardiogen side effects
Ovagen side effects
Cardiogen dosing ranges
Cardiac function support
1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year
Ovagen dosing ranges
Hepatic support
1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year
Cardiogen: Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium. Typical dose 1,000-5,000 mcg. Ovagen: Khavinson short peptide bioregulator targeting hepatocytes and liver function. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.
Stacking Cardiogen with Ovagen is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
Cardiogen is typically dosed: Once daily (SubQ) or sublingual for Cardiac function support. Ovagen is typically dosed: Once daily (SubQ) or sublingual for Hepatic support.
Cardiogen: Not FDA approved. Ovagen: Not FDA approved.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free